Symyx in Discussions with New Suitor after Bidding Climbs to $6.75 Per Share | GenomeWeb

By Bernadette Toner

This story has been updated from a version posted May 26 to include recent disclosures about the competing bid and to update share price information.

The proposed merger between Accelrys and Symyx Technologies may have hit a snag this week as Symyx disclosed that it will "engage in discussions" with an undisclosed firm that has made a competing offer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.